Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis
Clinical trial NCT00650026 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT00650026
- Sponsor
- Abbott
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.